The best example of this is CaM-N98S, which affects both RyR2-mediated Ca2+ release and CaV1.2 Ca2+-dependent inactivation, likely contributing to both CPVT and LQTS. This evidence concerns the gene CACNA1C and catecholaminergic polymorphic ventricular tachycardia.